menu
    • menu

    Company profile for Arctic Vision

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Arctic Vision will strive to become a leading ophthalmology company in China and Asia to fulfil the significant unmet medical needs in ophthalmology, for the ultimate benefit of patients and society. We are a biotech company focusing on the development of breakthrough therapies to address unmet needs in ophthalmology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Arctic VisionChina Flag
    Country
    Country
    China
    Address
    Address
    Suite 906-908, 9F, Tower II, Century Link, 1196 Century Avenue, Shanghai
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.arcticvision.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arctic Vision Announces the Acceptance in Australia of NDA for Suprachoroidal Use of Arcatus
    Arctic Vision Announces the Acceptance in Australia of NDA for Suprachoroidal Use of Arcatus

    10 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/10/2701644/0/en/Clearside-Biomedical-Asia-Pacific-Partner-Arctic-Vision-Announces-the-Acceptance-in-Australia-of-its-New-Drug-Application-for-Suprachoroidal-Use-of-Arcatus-for-the-Treatment-of-Uve.html

    GLOBENEWSWIRE
    10 Jul 2023
    Share Share
    Arctic Vision Begins Enrollment in PIII Trial of ARVN003 for Presbyopia
    Arctic Vision Begins Enrollment in PIII Trial of ARVN003 for Presbyopia

    04 Jul 2022

    // ASIAONE

    https://www.asiaone.com/business/arctic-vision-announces-first-patient-enrolled-phase-iii-clinical-trial-arvn003-presbyopia

    ASIAONE
    04 Jul 2022
    Share Share
    Arctic Vision Begins Dosing in Phase III Study of ARVN001 for UME
    Arctic Vision Begins Dosing in Phase III Study of ARVN001 for UME

    22 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/arctic-vision-announces-first-patient-dosed-in-phase-iii-study-of-arvn001-for-treatment-of-macular-edema-associated-with-uveitis-ume-301429973.html

    PRNEWSWIRE
    22 Nov 2021
    Share Share
    Arctic Vision Announces Addition of MydCombi to Eyenovia Commercialization Deal
    Arctic Vision Announces Addition of MydCombi to Eyenovia Commercialization Deal

    16 Sep 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/arctic-vision-announces-addition-of-novel-mydriatic-drug-mydcombi-arvn004-to-eyenovia-commercialization-deal-301378890.html

    PRNEWSWIRE
    16 Sep 2021
    Share Share
    Clearside Biomedical Expands XIPERE License Agreement with Arctic Vision
    Clearside Biomedical Expands XIPERE License Agreement with Arctic Vision

    09 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/09/2294162/0/en/Clearside-Biomedical-Expands-XIPERE-License-Agreement-with-Arctic-Vision-to-Include-Australia-New-Zealand-India-and-ASEAN-Countries.html

    GLOBENEWSWIRE
    09 Sep 2021
    Share Share
    NMPA clears Arctic Vision’s IND for phase III study of ARVN003 in presbyopia
    NMPA clears Arctic Vision’s IND for phase III study of ARVN003 in presbyopia

    04 Sep 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=142325&sid=2

    PHARMABIZ
    04 Sep 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search